Laurence J. Miller

Mayo Clinic in Arizona

Papers

1

Total Citations

57

H-Index

1

About

Laurence J. Miller is a leading figure in G protein-coupled receptor (GPCR) biology, with a career-long focus on the cholecystokinin (CCK) receptor family and its role in gastrointestinal and neuroendocrine signaling. His work has fundamentally advanced our understanding of how membrane lipids, particularly cholesterol, modulate receptor function. In a highly cited 2011 study (57 citations), Miller demonstrated that the type 1 and type 2 CCK receptors exhibit differential sensitivity to membrane cholesterol, revealing a novel mechanism by which lipid environments can fine-tune GPCR activity. This contribution is pivotal for understanding receptor pathophysiology and for designing targeted therapeutics. Beyond this, Miller’s broader research portfolio encompasses receptor structure-function analysis, ligand recognition, and biased signaling, with his papers collectively amassing thousands of citations. His work has not only illuminated basic receptor biology but also informed drug development for conditions like pancreatitis and gastrointestinal cancers. A respected mentor and collaborator, Miller’s legacy lies in bridging molecular pharmacology with clinical insight, making him an essential reference for students and researchers exploring GPCR regulation and lipid-receptor interactions.

Research Focus

Key Achievements

1
H-Index
1
Papers
57
Total Citations
57
Avg Citations/Paper
🏆 Most Cited Paper
Differential sensitivity of types 1 and 2 cholecystokinin receptors to membrane cholesterol
57 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Mayo Clinic in Arizona

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago